Published in Alzheimers Res Ther on September 15, 2015
"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74
Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06
Mild cognitive impairment--beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med (2004) 16.58
Automated Talairach atlas labels for functional brain mapping. Hum Brain Mapp (2000) 15.98
Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci (2005) 12.85
Measurement of functional activities in older adults in the community. J Gerontol (1982) 10.07
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol (2006) 9.99
Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol (2013) 9.43
MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol (1987) 8.48
CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA (2009) 7.29
Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease. Brain (2007) 6.39
Mild cognitive impairment: ten years later. Arch Neurol (2009) 5.02
Clinical practice. Mild cognitive impairment. N Engl J Med (2011) 4.16
Relationships between biomarkers in aging and dementia. Neurology (2009) 4.16
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol Aging (2009) 3.97
Rate of progression of mild cognitive impairment to dementia--meta-analysis of 41 robust inception cohort studies. Acta Psychiatr Scand (2008) 3.65
Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50
Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp (1997) 3.23
The role of the posterior cingulate cortex in cognition and disease. Brain (2013) 2.98
Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc (1989) 2.83
[Suggestions for utilization of the mini-mental state examination in Brazil]. Arq Neuropsiquiatr (2003) 2.77
Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations. J Neurol Neurosurg Psychiatry (2010) 2.44
Amyloid-first and neurodegeneration-first profiles characterize incident amyloid PET positivity. Neurology (2013) 1.74
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment. Alzheimers Res Ther (2013) 1.62
Development and validation of the Geriatric Anxiety Inventory. Int Psychogeriatr (2007) 1.51
Meta-analysis of amyloid-cognition relations in cognitively normal older adults. Neurology (2013) 1.51
Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping. Neuroimage (1999) 1.47
Functional impact of white matter hyperintensities in cognitively normal elderly subjects. Arch Neurol (2010) 1.36
Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology (2014) 1.31
What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus. Prog Neurobiol (2014) 1.29
Effects of white matter lesions and lacunes on cortical function. Arch Neurol (2004) 1.28
The serendipitous discovery of the brain's default network. Neuroimage (2011) 1.25
Education and occupation as proxies for reserve in aMCI converters and AD: FDG-PET evidence. Neurology (2008) 1.21
Clinical-neuroimaging characteristics of dysexecutive mild cognitive impairment. Ann Neurol (2009) 1.21
Are empirically-derived subtypes of mild cognitive impairment consistent with conventional subtypes? J Int Neuropsychol Soc (2013) 1.14
Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol (2009) 1.11
Insights into human behavior from lesions to the prefrontal cortex. Neuron (2014) 1.09
Predictive validity and diagnostic stability of mild cognitive impairment subtypes. Alzheimers Dement (2012) 1.08
A longitudinal follow-up of 550 mild cognitive impairment patients: evidence for large conversion to dementia rates and detection of major risk factors involved. J Alzheimers Dis (2013) 1.05
Subregions of the human superior frontal gyrus and their connections. Neuroimage (2013) 1.02
Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 0.99
Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol (2008) 0.95
Metabolic networks underlying cognitive reserve in prodromal Alzheimer disease: a European Alzheimer disease consortium project. J Nucl Med (2013) 0.92
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. Neuroimage Clin (2014) 0.91
Differences in hippocampal metabolism between amnestic and non-amnestic MCI subjects: automated FDG-PET image analysis. Q J Nucl Med Mol Imaging (2009) 0.86
Correlation between cognitive impairment and CSF biomarkers in amnesic MCI, non-amnesic MCI, and Alzheimer's disease. J Alzheimers Dis (2010) 0.86
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. J Alzheimers Dis (2013) 0.83
Comparison between two tests of delayed recall for the diagnosis of dementia. Arq Neuropsiquiatr (2006) 0.80
Does executive impairment define a frontal variant of Alzheimer's disease? Int Psychogeriatr (2010) 0.78
A score based on screening tests to differentiate mild cognitive impairment from subjective memory complaints. Neurol Int (2013) 0.77
Executive dysfunction. Continuum (Minneap Minn) (2015) 0.77